Jason Kang, MD, PhD

Jason is a Postdoctoral Scholar and Weill Neurohub Fellow. He earned his MD and PhD from West Virginia University. His current research focuses on several key areas of antibody engineering, including the development of monoclonal antibodies to prevent prenatal opioid exposure and to counter emerging drugs of abuse, such as xylazine. He is also working on engineering antibodies with modified Fc properties. Outside of lab, Jason enjoys cycling, snowboarding, and rooting for the Seahawks.